BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Lexigen Pharmaceuticals Corp. 

125 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-861-5300 Fax: 781-861-5301


SEARCH JOBS
Lexigen Pharmaceuticals Corp. is a leader in the creative development of genetically engineered proteins. The strategy of Lexigen Pharmaceuticals Corp. is to develop unique treatments for cancer and other serious, life-threatening diseases, and at the same time to develop broad technology platforms that will lead to new therapies.

Lexigen has two novel immunocytokines in clinical development. These antibody-cytokine fusion proteins target the immune system to specific cell types. Lexigen is developing the immunocytokines as cancer treatments, and simultaneously developing the immunocytokine concept as a broad, proprietary technology base.

Lexigen is an associate of Merck KGaA, Darmstadt, Germany, a multi-national pharmaceutical company with over 30,000 employees and annual revenues of approximately eight billion dollars. Thus, Lexigen combines the flexibility and creativity of a star-up biotech environment, with the financial stability, global presence, and commercial expertise of a large pharmaceutical company.

Last Updated 9-21-01


 Key Statistics


Email: info@lexigenpharm.com
Ownership: Private

Web Site: Lexigen Pharmaceuticals Corp.
Employees:
Symbol: 
 



Industry
Pharmaceutical

Segment
Drug Discovery





 Company News
Lexigen Pharmaceuticals Corp. to Present at the 29th Annual JPMorgan Healthcare Conference 1/5/2011 7:03:31 AM    More...
Lexigen Pharmaceuticals Corp. Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug 8/22/2007 8:59:41 AM    More...
Lexicon Genetics (LEXG) Achieves Second Performance Milestone In Genentech, Inc. (DNA) Alliance 10/19/2005 5:11:24 PM    More...

//-->